The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features
Open accessAbstract
OBJECTIVE: The aim of this study was to determine whether the frequency of TAR DNA-binding protein 43 (TDP-43) deposition in Alzheimer's disease (AD) differs across pathologically defined AD subtypes (hippocampal sparing [HpSp]; typical and limbic) and further examine the relationship between TDP-43, pathological subtype, and clinical features in AD. METHODS: We identified all cases with pathologically confirmed AD (NIA-Reagan intermediate-high probability, Braak stage IV-VI) independent of cognitive status (n = 188). Neurofibrillary tangle counts were performed using thioflavin-S microscopy in hippocampus and three neocortical regions, and all cases were subtyped: HpSp AD pathology (n = 19); typical AD pathology (n = 136); and limbic AD pathology (n = 33). TDP-43 immunoreactivity was performed in multiple brain regions to assess for the presence of TDP-43 and TDP-43 stage. All cases were clinically subclassified at presentation as amnestic AD dementia versus atypical AD dementia. Statistical analysis was performed using linear and penalized logistic regression to assess associations with pathological subtype, and the effects of TDP-43, accounting for possible interactions between pathological subtype and TDP-43. RESULTS: TDP-43 deposition was frequent in typical (59%) and limbic AD pathologies (67%), but not HpSp AD pathology (21%; p = 0.003). The observed associations of TDP-43 with greater memory loss, naming and functional decline, and smaller hippocampal volumes, closest to death, did not differ across AD pathological subtype. Clinical presentation was associated with pathological subtype (p = 0.01), but not TDP-43 (p = 0.69). INTERPRETATION: Although the frequency of TDP-43 deposition in AD varies by pathological subtype, the observed effects of TDP-43 on clinical/magnetic resonance imaging features are consistent across pathological subtypes. Clinical presentation in AD is driven by pathological subtype, not by TDP-43.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TDP-43 deposits are more common in typical AD and limbic-predominant AD than hippocampal-sparing AD [134].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Flagged first, then by citations
Research works printed but not linked: 3
- American Psychiatric Association, 2000, American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders
- Kaplan E, 1983, The Boston Namiing Test
- Benton AL, 1989, Manual. Multilingual Aphasia Examination
Cited by
Sorted by citations
Items 101–147 of 147
Huang, W., Huang, J., Kuang, N., Wu, J., Feng, F., Luo, Y., & Huang, N. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103290 · Cited by 12
Xie, X., Zhang, X., Li, S., & Du, W. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00784-0 · Cited by 11
Lavrova, A., Pham, N. T. T., Reid, R. I., Boeve, B. F., Knopman, D. S., Petersen, R. C., Nguyen, A. T., Reichard, R. R., Dickson, D. W., Jack, C. R., et al. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.03.001 · Cited by 11
Self-citationGu, J., Chu, D., Jin, N., Chen, F., & Liu, F. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190368 · Cited by 10
Incidence and morphology of secondary TDP-43 proteinopathies: Part 1
Acewicz, A., Stępień, T., Felczak, P., Tarka, S., & Wierzba‐Bobrowicz, T. (2022) · Folia Neuropathologica · doi:10.5114/fn.2022.120314 · Cited by 11
Dissecting the Many Faces of Frontotemporal Dementia: An Imaging Perspective
Pengo, M., Premi, E., & Borroni, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112867 · Cited by 9
Association of Hemoglobin A1C With TDP-43 Pathology in Community-Based Elders
Oveisgharan, S., Capuano, A. W., Nag, S., Agrawal, S., Barnes, L. L., Bennett, D. A., Arvanitakis, Z., & Schneider, J. A. (2021) · Neurology · doi:10.1212/wnl.0000000000012025 · Cited by 9
Lu, S., Zhang, S., Oung, S., Diedrich, J. K., Han, P., Arnold-García, O., Ohkubo, T., Arogundade, O. A., Vazquez‐Sanchez, S., Zhang, K., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01789-5 · Cited by 8
Liou, J., Li, J., Berardinelli, J., Jin, H., Santini, T., Noh, J., Farhat, N., Wu, M., Aizenstein, H. J., Mettenburg, J., et al. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf010 · Cited by 7
TDP-43 Pathology and Prionic Behavior in Human Cellular Models of Alzheimer’s Disease Patients
Cuevas, E. P., Rodríguez-Fernández, A., Palomo, V., Martı́nez, A., & Martín‐Requero, Á. (2022) · Biomedicines · doi:10.3390/biomedicines10020385 · Cited by 8
Inui, S., Kaneda, D., Sakurai, K., Morimoto, S., Uchida, Y., Abe, O., & Hashizume, Y. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.122894 · Cited by 6
Baghel, M. S., Burns, G. D., Tsapatsis, M., Mallika, A. P., Cruz, A. L., Cao, T., Chen, X. K., Rosa, I. D. L., Marx, S. R., Ye, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.26.600814 · Cited by 6
Ferreira, D., Chmiela, T., Eriksdotter, M., Jack, C. R., Kalpouzos, G., Marseglia, A., Mecocci, P., Nordberg, A. K., Religa, D., & Westman, E. (2026) · Journal of Internal Medicine · doi:10.1111/joim.70096 · Cited by 7
Celebrating neuropathology's contributions to Alzheimer's Disease Research Centers
Fischer, D. L., Grinberg, L. T., Ahrendsen, J. T., Beach, T. G., Bieniek, K. F., Castellani, R. J., Chkheidze, R., Cobos, I., Cohen, M. L., Crary, J. F., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70734 · Cited by 6
Self-citationLiou, J., Li, J., Berardinelli, J., Jin, H., Santini, T., Noh, J., Farhat, N., Wu, M., Aizenstein, H. J., Mettenburg, J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.083741 · Cited by 5
Ferraro, P. M., Filippi, L., Ponzano, M., Signori, A., Orso, B., Massa, F., Arnaldi, D., Caneva, S., Argenti, L., Losa, M., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241299843 · Cited by 4
CSF pTDP-43 across the Alzheimer's spectrum: Links to amyloid, APOE and vasculopathy
Rafiee, Z., Pocevičiūtė, D., Santiago, J., Mahmoud, R., Janelidze, S., Hansson, O., & Wennström, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107193 · Cited by 4
LATE, Hippocampal Sclerosis, and Primary Age-related Tauopathy
Ramanan, V. K., & Graff‐Radford, J. (2024) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001499 · Cited by 4
Abdi, Z., Yong, K. X. X., Schott, J. M., Gatt, A. P., Révész, T., Crutch, S. J., & Lashley, T. (2025) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.70007 · Cited by 5
A Precision Medicine Approach to Dementia Care: Syndrome, Etiology, and Copathology.
Fischer, D. L., & Seeley, W. W. (2023) · PubMed · Cited by 3
Alzheimer mimicry: LATE and PART
Bogdanović, N., Smailović, U., & Jelić, V. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02916-0 · Cited by 3
Zilioli, A., Mohanty, R., Rosenberg, A., Matton, A., Granberg, T., Hagman, G., Spallazzi, M., Ferreira, D., Kivipelto, M., & Westman, E. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-01972-2 · Cited by 2
Hypometabolic subtypes of AD are linked to comorbid hippocampal sclerosis and Lewy body pathology
Levin, F., Dyrba, M., Teipel, S. J., & Grothe, M. J. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01796-6 · Cited by 2
Structure, Function, Pathomechanisms and Targeting of TDP-43 in Neurodegeneration
Zhang, X., Zhang, B., Shang, Y., & Zou, L. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150063 · Cited by 1
Lavrova, A., Satoh, R., Tosakulwong, N., Weigand, S. D., Jack, C. R., Petersen, R. C., Nguyen, A. T., Reichard, R. R., Prudencio, M., Petrucelli, L., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261421241 · Cited by 1
Self-citationTDP-43: a critical amplifier of Alzheimer’s disease beyond amyloid and tau
Roy, A., Chhetry, S., Deka, H., Roy, R., Bhattacharya, P., Patel, B. K., & Borah, A. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.05.024 · Cited by 1
Artificial intelligence–based 3D segmentation of tangle‐associated TDP ‐43 in neurodegeneration
Uruk, G., Youssef, H., Gatto, R. G., Hossain, N., Whitwell, J. L., Reichard, R. R., & Josephs, K. A. (2026) · Brain Pathology · doi:10.1111/bpa.70131 · Cited by 1
Self-citationSimonetti, F., Zhong, W., Hutten, S., Uliana, F., Schifferer, M., Rezaei, A., Ramirez, L. M., Hochmair, J., Sankar, R., Gopalan, A. B., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.07.662960 · Cited by 1
Tauopathy primes co-filament assembly and dysfunction of TDP-43Preprint
Baghel, M. S., Burns, G. D., Mallika, A. P., Chen, X. K., Liu, F. L., Renganathan, S., Li, T., Troncoso, J. C., & Wong, P. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.11.723888 · Cited by 1
Caspases and Neurodegeneration☆
Citron, B. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00513-7
Uemura, M. T. (2024) · Journal of The Society of Japanese Women Scientists · doi:10.5939/sjws.240005
Xie, X., Zhang, X., Li, S., & Du, W. (2024) · Figshare · doi:10.6084/m9.figshare.26694390
Additional file 1 of LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease
Koper, M. J., Tomé, S. O., Gawor, K., Belet, A., Schoor, E. V., Schaeverbeke, J. M., Vandenberghe, R. R., Vandenbulcke, M., Ghebremedhin, E., Otto, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20887331
Xie, X., Zhang, X., Li, S., & Du, W. (2024) · Figshare · doi:10.6084/m9.figshare.26694393
Xie, X., Zhang, X., Li, S., & Du, W. (2024) · Figshare · doi:10.6084/m9.figshare.26694387
Song, H., Ameen‐Ali, K. E., Dietrich, C. K., Dollé, J.-P., Lee, E. B., Smith, D. H., Stewart, W. B., Jr., the CONNECT-TBI Investigators, Cortes, E., Crary, J., et al. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag040
Mounié, A., Sato, K., Nakashima, S., Kurihara, M., Ihara, R., Niimi, Y., Iwata, A., & Iwatsubo, T. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70460
Wu, L., Akingbade, T. O., Nelson, P. T., Wang, S. J., & Xu, B. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03027-0
TDP-43 subtypes shape transcriptomic signatures in Alzheimer’s diseasePreprint
Wang, X., Walker, A. C., Reeves, M. M., Bejarano, J. G., Song, Y., Dunmore, J. H., Yue, M., Rawlinson, B. D., Engelberg-Cook, E., Deture, M. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.22.733827
Self-citationFrom biology to therapy: advances in progranulin-related neurodegenerative diseases
Hu, S., Qiu, K., Zhen, F., & Zhou, X. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00042-z
Saifullah, K., Ridwan, A. R., Evia, A. M., Leurgans, S. E., Wagner, M., Bennett, D. A. A., Schneider, J. A., & Arfanakis, K. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71719
The UNC13A cryptic exon associates with cognitive impairment in Alzheimer’s disease
Reeves, M. M., Carpintero, S. A., Zanovello, M., Jansen‐West, K. R., Yue, M., Calliari, A., Song, Y., Dunmore, J. A., Cidfuentes, C. M., Ball, S., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02157-7
Self-citationDistinct Transcriptional States of TDP-43 Pathology in an Alzheimer’s Disease Mouse Model
Liu, J.-C., Liu, W.-J., Yu, L.-Q., Li, J., Sun, Y., Li, S., & Ma, Q. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01698-z
TMEM106B is a selective modulator of TDP‐43 pathology in Alzheimer's disease
Reeves, M. M., Calliari, A., Todd, T. W., Cidfuentes, C. M., Jansen‐West, K. R., Yue, M., Song, Y., Dunmore, J. A., Rawlinson, B. D., Engelberg-Cook, E., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71713
Self-citationTansey, M. G., Bozeat, S., Ackerman, P., Atri, A., Barnum, C. J., Brundin, P., de Carvalho, C. M. A., Fleisher, A., Graf, A., Head, E., et al. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70287
Self-citationTargeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy?
Buck, S. A., Madhavan, S. S., & Sanders, L. H. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00047-8
Uruk, G., Youssef, H., Gatto, R. G., Hossain, N., Bhaskaran, J. G., Tian, Y., Machulda, M. M., Petersen, R. C., Whitwell, J. L., Reichard, R. R., et al. (2026) · Cells · doi:10.3390/cells15201850
Self-citation
Metadata
- Authors
- Josephs, K. A., Whitwell, J. L., Tosakulwong, N., Weigand, S. D., Murray, M. E., Liesinger, A. M., Petrucelli, L., Senjem, M. L., Ivnik, R. J., Parisi, J. E., Petersen, R. C., & Dickson, D. W.
- Affiliations
- Departments of Neurology (Behavioral Neurology)
- Radiology (Radiology Research)
- Health Science Research (Biostatistics)
- Mayo Clinic (US)
- Neuropsychiatry (Neuropsychology)
- Laboratory Medicine and Pathology (Neuropathology)
- Corresponding author
- Josephs, Keith A.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2015-09-16
- Volume
- 78
- Issue
- 5
- Pages
- 697-709
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC4623932
- OpenAlex
- W1921675910
- Cited by
- 147
- References
- 39
- Citations by year
- 2026: 20 · 2025: 15 · 2024: 20 · 2023: 7 · 2022: 16 · 2021: 10 · 2020: 26 · 2019: 12 · 2018: 5 · 2017: 9 · 2016: 7
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R01 AG037491 [K.A.J.], R21-AG038736 [J.L.W.], and P50-AG016574 [R.C.P.])
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- TDP-43, Alzheimer's disease, pathological subtypes, hippocampal sparing, typical Alzheimer's disease, neurofibrillary tangles, clinical features, hippocampal volume, memory loss, functional decline
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Cognition, DNA-Binding Proteins, Female, Gene Frequency, Hippocampus, Humans, Limbic System, Male, Memory Disorders, Middle Aged, Neuropsychological Tests, Psychomotor Performance, Neurofibrillary Tangles, Age of Onset, Disease Progression, Neocortex, TDP-43 Proteinopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
